A Novel Loss-of-function Mutation in MYBPC3 Causes Familial Hypertrophic Cardiomyopathy with Extreme Intrafamilial

Y Peng1,2,3, J Xu1,2,3, Y Wang1,2,3

  • 1Department of Cardiology, the First Hospital of Lanzhou University, Lanzhou, China.

Insights

A novel deletion in the MYBPC3 gene was identified in a Chinese patient with hypertrophic cardiomyopathy (HCM). This finding underscores the importance of whole exome sequencing for diagnosing familial HCM.

Area of Science:

  • Genetics
  • Cardiology
  • Molecular Biology

Background:

  • Cardiomyopathies, particularly hypertrophic cardiomyopathy (HCM), are heart muscle diseases often caused by genetic mutations.
  • MYBPC3 gene mutations are a common cause of HCM, but exhibit significant variability in disease presentation.
  • Understanding genetic underpinnings is crucial for diagnosing and managing HCM.

Purpose of the Study:

  • To investigate the genetic cause of hypertrophic cardiomyopathy in a Chinese patient.
  • To identify novel mutations in the MYBPC3 gene associated with HCM.
  • To evaluate the utility of whole exome sequencing in diagnosing familial HCM.

Main Methods:

  • Whole exome sequencing was performed on a patient diagnosed with HCM.
  • Genetic variant analysis was conducted to identify mutations in the MYBPC3 gene.
  • Segregation analysis was performed within the patient's family.

Main Results:

  • A novel heterozygous deletion (c.3781_3785delGAGGC) in exon 33 of the MYBPC3 gene was identified in the proband.
  • This deletion results in a frameshift mutation (p.Glu1261Thrfs*3), predicted to produce a truncated MYBPC3 protein.
  • The variant was found in the proband's father but not in the mother, consistent with familial inheritance.

Conclusions:

  • A novel MYBPC3 gene deletion is associated with hypertrophic cardiomyopathy in this Chinese family.
  • Whole exome sequencing is a valuable tool for the molecular diagnosis of familial HCM.
  • Further research is needed to understand the phenotypic heterogeneity associated with MYBPC3 mutations.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
20
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
26
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
14
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
14
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
21
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
247